Asset Details
Do you wish to reserve the book?
Viral Load as a Predictor of Outcome in Crimean-Congo Hemorrhagic Fever
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Viral Load as a Predictor of Outcome in Crimean-Congo Hemorrhagic Fever
Do you wish to request the book?
Viral Load as a Predictor of Outcome in Crimean-Congo Hemorrhagic Fever
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Viral Load as a Predictor of Outcome in Crimean-Congo Hemorrhagic Fever
2007
Overview
Crimean-Congo hemorrhagic fever (CCHF) is a potentially fatal disease affecting multiple organ systems. To determine the association between viral load and severity of CCHF infection, quantitative measurement of CCHF virus was performed using 1-step reverse-transcriptase polymerase chain reaction for 36 patients with CCHF infection. Viral loads ranged from 1.1 × 103 copies/mL to ⩾ 9.9 × 109 copies/mL. Nine (25%) of 36 patients died. In 8 of the 9 patients with fatal outcomes, viral loads were detected that were ⩾1 × 109 copies/mL, whereas in 25 of the 26 patients with nonfatal outcomes, viral loads were detected that were <1 × 109 copies/mL (P < .001). A viral load ⩾1 × 109 RNA copies/mL can be considered to predict a fatal outcome with a positive predictive value of 80%, with 88.9% sensitivity and 92.6% specificity. We suggest that viral load is a measure of the severity of CCHF.
Publisher
The University of Chicago Press
